Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanistic comparison of infliximab and etanercept in rheumatoid arthritis and psoriatic arthritis
2006-000363-28Phase 4Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Apr 2006
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of infliximab and etanercept in rheumatoid arthritis (RA) and psoriatic arthritis (PsA) (2 arms), sponsored by NHS Greater Glasgow and Clyde. Started Apr 2006; status: completed.
02
Drugs
infliximabetanercept
03
Conditions
rheumatoid arthritis (RA)psoriatic arthritis (PsA)
Beyond the preview
Go deeper on 2006-000363-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000363-28.